Matthew Hepburn, M.D.

U.S. Office of Science and Technology Policy, Executive Office of the President
Senior Advisor To the Director, Pandemic Prevention
Dr. Hepburn joined the White House Office of Science and Technology Policy and will manage the “American Pandemic Preparedness” agenda across the various agencies of the U.S. government

Prior, Dr. Hepburn was the vaccine development lead of Operation Warp Speed, the White House’s effort to hasten delivery of COVID-19 vaccine under the Trump administration and continued with a different name in the Biden Administration, known as the Countermeasures Acceleration Group. He is an infectious disease physician who has served in the U.S. Army Medical Corps. He has had a distinguished career in military medicine, treating patients and leading innovations to improve the health of those serving in the Department of Defense.

With his expertise in operational medicine, research and response, Dr. Hepburn served in the White House in efforts to prepare for the current pandemic, after the H1N1 influenza pandemic of 2009, helping to develop policy in detection and treatment during outbreaks. During his tenure at the Defense Advanced Research Projects Agency, Dr. Hepburn expanded diagnostic and therapeutic countermeasures, including mRNA vaccines delivered during the COVID-19 pandemic and predictive analytical tools for enhanced medical outcomes.

Dr. Hepburn attended Brooke Army Medical Center, Internal Medicine Residency and Infectious Diseases Fellowship program, Fort Sam Huston, Texas. Received his Doctor of Medicine and Bachelor of Science in biomedical engineering degrees from Duke University.

Dr. Hepburn’s awards include Bronze Star, Defense Meritorious Service Medal, Meritorious Service Medal, Army Commendation Medal (X4) and Army Achievement Medal (X3).